ReviewCurrent gastroenterology reports2026
Wearable Technologies in Gastrointestinal Disorders: Current Evidence and Future Directions.
Review in Current gastroenterology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
purpose of reviewGastrointestinal disorders fluctuate between clinical encounters, creating a need for objective longitudinal monitoring. We review wearable technologies across gastrointestinal disorders, emphasizing clinical applications, current evidence, and barriers to implementation. RECENT
findingsWearables capture physiologic, biochemical, and acoustic signals relevant to gastrointestinal disease. In inflammatory bowel disease, wearable-derived physiologic changes may precede inflammatory and symptomatic flares and help distinguish inflammatory from non-inflammatory symptoms. Sweat biosensors can measure inflammatory analytes, including calprotectin. Beyond inflammatory bowel disease, autonomic measures characterize disorders of gut-brain interaction, electrogastrographic and acoustic devices assess gastrointestinal motility, and activity and sleep metrics may aid postoperative recovery assessment and risk stratification in chronic liver disease. Evidence remains predominantly observational, and validated clinical thresholds are lacking, limiting the current clinical applicability of wearable derived signals. Wearables enable continuous, noninvasive monitoring across gastrointestinal disorders, but prospective trials are needed to establish clinical utility, actionable thresholds, workflow integration, and patient-centered implementation, and demonstrate improvement in clinically meaningful outcomes.
Indexed as
Identifiers
42955466What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.